Journal article
Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation
K Gadsbøll, OB Petersen, V Gatinois, H Strange, B Jacobsson, R Wapner, JR Vermeesch, I Vogel, A Shand, B Nowakowska, B Peterlin, E Machtejeviene, F Sethna, F Stipoljev, F Szirko, FR Grati, G Minarik, G Duncombe, H Helmer, H Hardardottir Show all
Acta Obstetricia Et Gynecologica Scandinavica | WILEY | Published : 2020
DOI: 10.1111/aogs.13841
Abstract
Introduction: Noninvasive prenatal testing (NIPT) using cell-free fetal DNA has increasingly been adopted as a screening tool for fetal aneuploidies. Several studies have discussed benefits and limitations of NIPT compared with both ultrasound and invasive procedures, but in spite of some shortcomings NIPT has become extensively used within the last 5 years. This study aims to describe the current use of NIPT in Europe, Australia and the USA. Material and methods: We conducted a survey to describe the current use of NIPT. Colleagues filled in a simple email-based questionnaire on NIPT in their own country, providing information on (a) access to NIPT, (b) NIPT’s chromosomal coverage, (c) fina..
View full abstractGrants
Awarded by Novo Nordisk Fonden
Funding Acknowledgements
Ida Vogel is funded by a grant from the Novo Nordic Foundation: NNF16OC0018772. Olav Bennike B. Petersen holds a professorship funded by Novo Nordisk Foundation grant NNFSA170030576.